# Food Effects of GST-HG171 Tablets Combined With Ritonavir in Healthy Chinese Participants

> **NCT06084507** · PHASE1 · UNKNOWN · sponsor: **Fujian Akeylink Biotechnology Co., Ltd.** · enrollment: 18 (estimated)

## Conditions studied

- COVID-19 Respiratory Infection

## Interventions

- **DRUG:** GST-HG171/ritonavir
- **DRUG:** ritonavir

## Key facts

- **NCT ID:** NCT06084507
- **Lead sponsor:** Fujian Akeylink Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-04
- **Primary completion:** 2023-05-23
- **Final completion:** 2023-12-27
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2023-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06084507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06084507, "Food Effects of GST-HG171 Tablets Combined With Ritonavir in Healthy Chinese Participants". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT06084507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*